These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21129316)

  • 1. [Metabolic syndrome in schizophrenia].
    Nyboe L; Videbech P
    Ugeskr Laeger; 2010 Dec; 172(49):3399-404. PubMed ID: 21129316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome and schizophrenia: the latest evidence and nursing guidelines for management.
    Usher K; Foster K; Park T
    J Psychiatr Ment Health Nurs; 2006 Dec; 13(6):730-4. PubMed ID: 17087676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
    Yogaratnam J; Biswas N; Vadivel R; Jacob R
    East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Need for lifestyle intervention: how to begin.
    Foreyt JP
    Am J Cardiol; 2005 Aug; 96(4A):11E-14E. PubMed ID: 16098837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.
    Barnett AH; Mackin P; Chaudhry I; Farooqi A; Gadsby R; Heald A; Hill J; Millar H; Peveler R; Rees A; Singh V; Taylor D; Vora J; Jones PB
    J Psychopharmacol; 2007 Jun; 21(4):357-73. PubMed ID: 17656425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and cardiovascular disease.
    Citrome L
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):84-93. PubMed ID: 16280341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizophrenia, antipsychotics and metabolic disease.
    Reynolds GP
    J Psychopharmacol; 2007 Jun; 21(4):355-6. PubMed ID: 17656424
    [No Abstract]   [Full Text] [Related]  

  • 8. Description of a healthy lifestyle intervention for people with serious mental illness taking second-generation antipsychotics.
    Park T; Usher K; Foster K
    Int J Ment Health Nurs; 2011 Dec; 20(6):428-37. PubMed ID: 21564457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological perspectives. Metabolic syndrome: schizophrenia and atypical antipsychotics.
    Keltner NL
    Perspect Psychiatr Care; 2006 Aug; 42(3):204-7. PubMed ID: 16916424
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of lifestyle interventions and weight management in schizophrenia.
    Bushe C; Haddad P; Peveler R; Pendlebury J
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):28-35. PubMed ID: 16280335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication.
    De Hert MA; van Winkel R; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
    Schizophr Res; 2006 Mar; 83(1):87-93. PubMed ID: 16481149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of antipsychotic medication on metabolic syndrome.
    Jones M; Jones A
    Nurs Stand; 2008 Aug 6-12; 22(48):43-8. PubMed ID: 18727355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up interventions in persons with schizophrenia and metabolic syndrome.
    Kølbæk P; Schiöth E; Aagaard J; Munk-Jørgensen P
    Aust N Z J Psychiatry; 2014 Nov; 48(11):1059-60. PubMed ID: 25277542
    [No Abstract]   [Full Text] [Related]  

  • 14. Exercise, diet and educational interventions for metabolic syndrome in persons with schizophrenia: A systematic review.
    Gurusamy J; Gandhi S; Damodharan D; Ganesan V; Palaniappan M
    Asian J Psychiatr; 2018 Aug; 36():73-85. PubMed ID: 29990631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenia, obesity, and antipsychotic medications: what can we do?
    Citrome L; Vreeland B
    Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications.
    Faulkner G; Cohn TA
    Can J Psychiatry; 2006 Jul; 51(8):502-11. PubMed ID: 16933587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome among psychiatric inpatients with schizophrenia in Indonesia.
    Marthoenis M; Aichberger MC; Puteh I; Syahrial S; Schouler-Ocak M
    Asian J Psychiatr; 2015 Jun; 15():10-4. PubMed ID: 25910596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiometabolic Risks in Schizophrenia and Directions for Intervention, 1: Magnitude and Moderators of the Problem.
    Andrade C
    J Clin Psychiatry; 2016 Jul; 77(7):e844-7. PubMed ID: 27464317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of the metabolic syndrome in IGT subjects in a lifestyle intervention: results from the SLIM study.
    den Boer AT; Herraets IJ; Stegen J; Roumen C; Corpeleijn E; Schaper NC; Feskens E; Blaak EE
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1147-53. PubMed ID: 23462149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.